The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The race to supply obesity drugs is so competitive that one early-stage startup is already striking a deal for commercial ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of employers are considering covering the blockbuster weight-loss drugs ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...